| The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary … G Fernández-Juárez, J Rojas-Rivera, AE van De Logt, J Justino, ... Kidney international 99 (4), 986-998, 2021 | 139 | 2021 |
| Renal biopsy in type 2 diabetic patients E Espinel, I Agraz, M Ibernon, N Ramos, J Fort, D Serón Journal of Clinical Medicine 4 (5), 998-1009, 2015 | 92 | 2015 |
| The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis E Garcia-Vives, C Solé, T Moliné, M Vidal, I Agraz, J Ordi-Ros, ... International journal of molecular sciences 21 (4), 1372, 2020 | 64 | 2020 |
| Mesangial C4d deposits in early IgA nephropathy A Segarra, K Romero, I Agraz, N Ramos, A Madrid, C Carnicer, E Jatem, ... Clinical Journal of the American Society of Nephrology 13 (2), 258-264, 2018 | 60 | 2018 |
| Renal transplantation with limit donors: to what should the good results obtained be attributed? R Sola, LL Guirado, AL Navidad, F Caballero, I Agraz, M Diaz, D Paredes, ... Transplantation 66 (9), 1159-1163, 1998 | 57 | 1998 |
| Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus J Caro, E Gutiérrez-Solís, J Rojas-Rivera, I Agraz, N Ramos, C Rabasco, ... Nephrology Dialysis Transplantation 30 (3), 467-474, 2015 | 56 | 2015 |
| Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors C García-Carro, M Bolufer, R Bury, Z Castañeda, E Muñoz, E Felip, ... Nephrology Dialysis Transplantation 37 (5), 887-894, 2022 | 47 | 2022 |
| Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience A Segarra, KV Arredondo, J Jaramillo, E Jatem, MT Salcedo, I Agraz, ... Lupus 29 (2), 118-125, 2020 | 46 | 2020 |
| Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring M Waldman, MJ Soler, C García-Carro, L Lightstone, T Turner-Stokes, ... Kidney international 99 (1), 227-237, 2021 | 45 | 2021 |
| Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus A Segarra-Medrano, E Jatem-Escalante, C Carnicer-Cáceres, ... Nefrología (English Edition) 34 (4), 491-497, 2014 | 44 | 2014 |
| Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis E Garcia-Vives, C Solé, T Moliné, AM Alvarez-Rios, M Vidal, I Agraz, ... Lupus 28 (3), 396-405, 2019 | 43 | 2019 |
| Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase … A Segarra-Medrano, E Jatem-Escalante, MT Quiles-Pérez, MT Salcedo, ... Nefrología (English Edition) 34 (3), 353-359, 2014 | 42 | 2014 |
| Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience D Oleas, M Bolufer, I Agraz, E Felip, E Munoz, A Gabaldon, R Bury, ... Clinical Kidney Journal 14 (5), 1364-1370, 2021 | 38 | 2021 |
| Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody–associated vasculitis: influence on the disease outcome E Garcia-Vives, A Segarra-Medrano, F Martinez-Valle, I Agraz, ... The Journal of Rheumatology 47 (3), 407-414, 2020 | 35 | 2020 |
| Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type 1 and transforming growth factor β1 in predicting the extent of … A Segarra-Medrano, C Carnicer-Caceres, N Valtierra-Carmeno, ... Nefrología (English Edition) 37 (5), 531-538, 2017 | 32 | 2017 |
| Risk factors for non-diabetic renal disease in diabetic patients S Bermejo, E González, K López-Revuelta, M Ibernon, D López, ... Clinical Kidney Journal 13 (3), 380-388, 2020 | 31 | 2020 |
| Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome A Segarra, E Jatem, MT Quiles, MA Arbós, E Ostos, H Ostos, N Valtierra, ... Nefrología (English Edition) 34 (1), 46-52, 2014 | 30 | 2014 |
| How to assess diabetic kidney disease progression? From albuminuria to GFR C García-Carro, A Vergara, S Bermejo, MA Azancot, ... Journal of Clinical Medicine 10 (11), 2505, 2021 | 28 | 2021 |
| The new era for reno-cardiovascular treatment in type 2 diabetes C García-Carro, A Vergara, I Agraz, C Jacobs-Cachá, E Espinel, D Seron, ... Journal of clinical medicine 8 (6), 864, 2019 | 27 | 2019 |
| Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different … AS Medrano, EJ Escalante, CC Cáceres, IA Pamplona, MTS Allende, ... Biomarkers 20 (1), 77-83, 2015 | 27 | 2015 |
